Alpine Immune Sciences

Founded in 2015 by a team responsible for the FDA’s approval of the world’s first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies. Alpine Immune Sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other diseases.
Type
Private
HQ
Seattle, US
Founded
2015
Alpine Immune Sciences was founded in 2015 and is headquartered in Seattle, US

Alpine Immune Sciences Office Locations

Alpine Immune Sciences has an office in Seattle
Seattle, US (HQ)
200 Elliott Avenue West
Show all (1)

Alpine Immune Sciences Financials and Metrics

Summary Metrics

Founding Date

2015

Total Funding

$49.3 m

Latest funding size

$48 m

Time since last funding

over 1 year

Investors

Alpine Immune Sciences's latest funding round in June 2016 was reported to be $48 m. In total, Alpine Immune Sciences has raised $49.3 m

Alpine Immune Sciences's Web-traffic and Trends

Alpine Immune Sciences Online and Social Media Presence

Alpine Immune Sciences Company Life and Culture

You may also be interested in